DuPont de Nemours Inc has recently appreciated in value with a 5.2% increase since its last earnings report. The stock has been upgraded to a strong buy, but has underperformed compared to competitors on some days. DuPont has planned a quarterly dividend of $0.38 and has opened a world-class probiotics fermentation unit. The company's stock has a potential rally forecast of 29%. UBS Group and Barclays have increased their price target for DuPont to $98.00 and $85.00 respectively. The stock has also been upgraded by Citigroup. Strategic SWOT insights highlight the company's marketing strategy and potential growth areas. DuPont plans on splitting into three separate companies. Analysts expect its international revenue to keep increasing. The company's Q1 2024 earnings show an adjusted EPS beating estimates and the company expects to surpass earnings estimates. DuPont is favored by 76% of institutional owners. Its stock has also seen a high volume of call options, but investors have not been profitable in the past five years. DuPont is planning a $1 billion stock buyback and a dividend hike after a Q4 profit beat. The company has used debt extensively in its operations. DuPont performed well in Q4 with earnings surpassing estimates.
Dupont De Nemours DD News Analytics from Thu, 02 Nov 2023 07:00:00 GMT to Sun, 02 Jun 2024 15:12:14 GMT -
Rating 6
- Innovation 5
- Information 7
- Rumor 4
